BCL2 and cancer: On the other hand, as the ATV injection period is increased (τA = 0 → 1 → 4 → 10), the Bcl-2 level is increased and BAX activities are reduced (Fig 9D), reducing the probability of apoptotic death of cancer cells through decreases in persistence of apoptosis (Fig 9E).